Caxton Associates (UK)’s Brink's BCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$758K Sell
8,021
-6,140
-43% -$640K 0.01% 464
2026
Q1
$1.47M Buy
14,161
+12,188
+618% +$1.46M 0.03% 286
2025
Q4
$230K Buy
+1,973
New +$226K ﹤0.01% 682
2025
Q2
Sell
-20,876
Closed -$1.8M 701
2025
Q1
$1.8M Buy
+20,876
New +$1.89M 0.06% 182

Other funds holding BCO

Caxton Associates (UK)'s BCO Position: Q2 2026 in Review

Caxton Associates (UK) reduced its Brink's (BCO) stake by 43% in Q2 2026, selling an estimated $640K and leaving 8,021 shares worth $758K. The position accounts for 0.01% of the portfolio, ranked #464.

Caxton Associates (UK) first reported a position in BCO in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.8M in Q1 2025. 358 funds tracked by Wall St. Rank hold BCO as of Q2 2026.

  • Caxton Associates (UK) held 8,021 shares of Brink's worth $758K as of Q2 2026.
  • Caxton Associates (UK) sold 6,140 Brink's shares in Q2 2026, an estimated $640K.
  • Brink's made up 0.01% of Caxton Associates (UK)'s portfolio in Q2 2026, its #464 holding.
  • Caxton Associates (UK) first reported a position in Brink's in Q1 2025 and has held it in 4 quarters since.
  • Caxton Associates (UK)'s Brink's position peaked at $1.8M in Q1 2025.
  • 358 funds tracked by Wall St. Rank held Brink's as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.